Recombinant Human FAM89B Protein，GST

FANCG, a crucial protein involved in the fanconi anemia (FA) pathway, plays a significant role in maintaining genomic stability by facilitating DNA repair mechanisms. Fanconi anemia is a rare genetic disorder characterized by hypersensitivity to DNA cross-linking agents, resulting in bone marrow failure, malignancies, and various developmental abnormalities. The FANCG gene, part of a complex network of FA genes, encodes a protein that is essential for the repair of DNA interstrand crosslinks, which can be induced by environmental agents or during normal cellular processes. Understanding the structure, function, and interactions of FANCG is vital for elucidating the pathological mechanisms underlying FA and for developing potential therapeutic strategies. Recent advancements in recombinant protein technology have enabled the production of purified FANCG for detailed biochemical and structural studies. This research aims to provide insights into the molecular functions of FANCG, its role in the FA pathway, and its potential as a target for innovative treatments that could mitigate the effects of DNA damage in FA patients and improve their life expectancy and quality of life. As the study of FANCG continues to progress, it holds promise for broadening our understanding of DNA repair mechanisms and their implications in cancer biology and other genetic disorders.